Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Change in Inventory (2021 - 2025)

Biote (BTMD) has 5 years of Change in Inventory data on record, last reported at $4.1 million in Q3 2025.

  • For Q3 2025, Change in Inventory rose 274.82% year-over-year to $4.1 million; the TTM value through Sep 2025 reached $997000.0, down 75.42%, while the annual FY2024 figure was -$3.7 million, 160.91% down from the prior year.
  • Change in Inventory reached $4.1 million in Q3 2025 per BTMD's latest filing, up from -$661000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.2 million in Q4 2023 and bottomed at -$2.4 million in Q2 2023.
  • Average Change in Inventory over 5 years is $592352.9, with a median of $267000.0 recorded in 2024.
  • Peak YoY movement for Change in Inventory: skyrocketed 786.95% in 2023, then crashed 1169.33% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $464000.0 in 2021, then surged by 128.88% to $1.1 million in 2022, then surged by 487.1% to $6.2 million in 2023, then tumbled by 124.62% to -$1.5 million in 2024, then skyrocketed by 370.03% to $4.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Inventory were $4.1 million in Q3 2025, -$661000.0 in Q2 2025, and -$952000.0 in Q1 2025.